Clinical Trial Finder Search Results

About the Fight CRC Clinical Trial Finder

This Trial Finder is a one-stop place to find and learn more about high-impact clinical trials for colorectal cancer patients with advanced colon or rectal cancer. Originally created by the late Dr. Tom Marsilje as a curated spreadsheet of trials, the FightCRC’s Trial Finder is a resource to find research studies that are open in your geography, and for which you may be eligible. The current data is now for metastatic, stage IV patients with both MSS and MSI-H status. The list of trials here is sourced from the ClinicalTrials.gov website and curated with Comments and Helpful Links. The searches can be focused on immunotherapy-centered trials and narrowed to studies enrolling patients who already have received immunotherapies.

Medical Disclaimer

The information contained in this website is not intended to recommend the self management of health problems, medical conditions or wellness. It is not intended to endorse or recommend any particular type of medical treatment, physician or treatment facility. Should any reader have any health care related questions, promptly call or consult your physician or healthcare provider. The information contained in this website should NOT be used by any reader to disregard medical and/or health related advice or provide a basis to delay consultation with a physician or a qualified healthcare provider. Fight Colorectal Cancer disclaims any liability based on information provided in this website.

Ubicación

MS status

Recruitment Status

Fase

Drogas

Inmunoterapia previa permitida

NCT ID

Title key word search

Fecha en que se añadió el juicio

From To

View:

Compact Expanded

PDF Excel CSV

NCT ID	Title	Fase	Date Added	Ubicación	Prior IO Allowed	CRC-directed	Status	Drogas	Etiquetas
NCT ID NCT06014502	TitleStudy to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors	Fase Fase 1	Date Added 2023-08-28	Ubicación Louisiana, United States Texas, United States	Prior IO Allowed No	CRC-directed No	Status Reclutamiento	Drogas IMGS-001	Etiquetas MSI-H/ MMRd
NCT ID NCT06013111	TitleAn Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti-CEA-CAR-T Cells Injection in Patients With CEA+ Locally Advanced and/or Metastatic Solid Tumors	Fase Fase 1	Date Added 2023-08-28	Ubicación China	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT06010901	TitleA Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer.	Fase Fase 1	Date Added 2023-08-25	Ubicación China	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas Anlotinib hydrochloride capsules, Penpulimab Injection, TQB2618 injection	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT06011772	TitleA Phase 0 Study of EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer	Fase Fase inicial 1	Date Added 2023-08-25	Ubicación New York, United States	Prior IO Allowed Sí	CRC-directed Sí	Status Suspendido	Drogas fluorouracil, Irinotecan, Leucovorin, oxaliplatin	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT06008119	TitleEfficacy and Safety of Tunlametinib Plus Vemurafenib in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer	Fase Fase 3	Date Added 2023-08-23	Ubicación China	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas Doublets Chemotherapy ± Bevacizumab or Doublets Chemotherapy ± Cetuximab, Tunlametinib plus Vemurafenib	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT06006923	TitleRegorafenib in Combination With Pembrolizumab or Pembrolizumab for MSI-H Colorectal Cancer	Fase Fase 2	Date Added 2023-08-23	Ubicación California, United States Florida, United States Illinois, United States Pennsylvania, United States Washington, United States	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas Pembrolizumab, Regorafenib, Keytruda, Stivarga	Etiquetas MSI-H/ MMRd
NCT ID NCT05999812	TitleClinical Trial of All-trans-retinoic Acid, Bevacizumab and Atezolizumab in Colorectal Cancer	Fase Fase 2	Date Added 2023-08-21	Ubicación Texas, United States	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas all trans Retinoic Acid, Atezolizumab, Bevacizumab	Etiquetas MSS/ MMRp
NCT ID NCT05990543	TitleCombination of Nelmastobart and Capecitabine Therapy in Metastatic Colorectal Cancer	Fase Fase 1	Date Added 2023-08-14	Ubicación	Prior IO Allowed Sí	CRC-directed Sí	Status Aún no se ha contratado	Drogas Nelmastobart and Capecitabine	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT05976906	TitleUniversal Dual-target NKG2D-NKp44 CAR-T Cells in Advanced Solid Tumors	Fase Fase 1	Date Added 2023-08-04	Ubicación China	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT05973487	TitleA Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors	Fase Fase 1	Date Added 2023-08-03	Ubicación Arizona, United States California, United States Connecticut, United States Florida, United States Illinois, United States Kentucky, United States Michigan, United States Minnesota, United States New York, United States North Carolina, United States Ohio, United States Oklahoma, United States Oregon, United States Pennsylvania, United States Tennessee, United States Texas, United States	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp

Showing 51 to 60 of 299 entries